Zobrazeno 1 - 10
of 487
pro vyhledávání: '"Emil J Freireich"'
Autor:
Gautam Borthakur, Michael G. Rosenblum, Moshe Talpaz, Naval Daver, Farhad Ravandi, Stefan Faderl, Emil J. Freireich, Tapan Kadia, Guillermo Garcia-Manero, Hagop Kantarjian, Jorge E. Cortes
Publikováno v:
Haematologica, Vol 98, Iss 2 (2013)
We conducted a phase 1 study of an anti-CD33 immunotoxin, humanized monoclonal antibody M195 conjugated to recombinant gelonin (HUM-195/rGEL), in patients with relapsed, refractory myeloid leukemias. Twenty-eight patients received the construct intra
Externí odkaz:
https://doaj.org/article/9fbeb5ba6ab54ef3bacf594a76ad99bf
Publikováno v:
Cancer. 124:4301-4313
Historically, progress in leukemia research has been slow, but it has accelerated recently as a result of understanding the pathophysiology of leukemias and implementing more effective and targeted therapies. This review summarizes the progress acros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94b8117dc8eb8dc17f9fb03c916ee9ff
https://doi.org/10.1002/cncr.31669
https://doi.org/10.1002/cncr.31669
Autor:
Guillermo Garcia-Manero, Courtney D. DiNardo, Sherry Pierce, Richard E. Champlin, Graciela M. Nogueras-Gonzalez, Carlos E. Bueso-Ramos, Naval Daver, Aron Simkins, Nitin Jain, Farhad Ravandi, Emil J. Freireich, Marina Konopleva, Elias Jabbour, Michael J. Keating, Susan O'Brien, Elizabeth J. Shpall, Hagop M. Kantarjian, Jorge E. Cortes, Tapan M. Kadia, Xuelin Huang
Publikováno v:
Cancer. 124:2534-2540
BACKGROUND The prognosis is poor for patients who have relapsed-refractory acute myelogenous leukemia (AML). Most published reports analyzed results from therapies in first-salvage AML or in studies that were conducted before 2000. Several novel agen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e46e068cf2ce19f635e36548511bdf0c
https://doi.org/10.1002/cncr.31370
https://doi.org/10.1002/cncr.31370
Autor:
Chitra Hosing, Fleur M. Aung, Benjamin Lichtiger, Issa F. Khouri, Emil J. Freireich, Roland L. Bassett
Publikováno v:
International Journal of Hematology and Blood Disorders. 2:1-9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44ad065aa8bb77d2d6843966560496c1
https://doi.org/10.15226/2639-7986/2/3/00115
https://doi.org/10.15226/2639-7986/2/3/00115
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41838b2c61bcb7e18d7cb534774a2645
https://doi.org/10.1016/s2152-2650(20)30439-0
https://doi.org/10.1016/s2152-2650(20)30439-0
Publikováno v:
Cancer. 124(22)
Historically, progress in leukemia research has been slow, but it has accelerated recently as a result of understanding the pathophysiology of leukemias and implementing more effective and targeted therapies. This review summarizes the progress acros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0a8db481224941db1c8ad6ccec46b1cb
https://pubmed.ncbi.nlm.nih.gov/31026073
https://pubmed.ncbi.nlm.nih.gov/31026073
Autor:
Hagop M, Kantarjian, Courtney D, DiNardo, Graciela M, Nogueras-Gonzalez, Tapan M, Kadia, Elias, Jabbour, Carlos E, Bueso-Ramos, Susan M, O'Brien, Marina, Konopleva, Nitin B, Jain, Naval G, Daver, Elizabeth J, Shpall, Richard E, Champlin, Aron, Simkins, Guillermo, Garcia-Manero, Michael J, Keating, Xuelin, Huang, Jorge E, Cortes, Sherry A, Pierce, Farhad, Ravandi, Emil J, Freireich
Publikováno v:
Cancer. 124(12)
The prognosis is poor for patients who have relapsed-refractory acute myelogenous leukemia (AML). Most published reports analyzed results from therapies in first-salvage AML or in studies that were conducted before 2000. Several novel agents and stra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a8c758338e34f6fbdf7c849f65f543c8
https://pubmed.ncbi.nlm.nih.gov/29645075
https://pubmed.ncbi.nlm.nih.gov/29645075
Autor:
Emil J. Freireich
Publikováno v:
Neoplastic Diseases of the Blood ISBN: 9783319642628
Neoplastic Diseases of the Blood ISBN: 9781461437635
Neoplastic Diseases of the Blood ISBN: 9781461437635
The recognition of acute leukemia as a malignancy of the blood cells is usually credited to Virchow (Milestones in Leukemia Research and Therapy, The John Hopkins University Press, London, 1991) as is the term leukemia (Weisses Blut) (Neue Notizen Ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c21994ce20b790ee360d026d19218ca6
https://doi.org/10.1007/978-3-319-64263-5_11
https://doi.org/10.1007/978-3-319-64263-5_11
Publikováno v:
The Hematologist. 14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2484df75362e42a5dc30b6fb0438840
https://doi.org/10.1182/hem.v14.3.7289
https://doi.org/10.1182/hem.v14.3.7289
Autor:
Fleur M. Aung, Fern, o Martinez, Emil J. Freireich, Tapan M. Kadia, Elias Jabbour, Courtney D. DiNardo, Hagop M. Kantarjian, Naval Daver, Benjamin Lichtiger, Sherry Pierce
Publikováno v:
Journal of Blood Disorders & Transfusion.
Background: Patients with Acute Myeloid Leukemia (AML) experience profound neutropenia; infections remain the leading cause of morbidity and mortality. Transfusion of functional non-irradiated allogeneic granulocytes may treat or prevent infections i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1658e522e39dc7d54d716d5bb161eeb7
https://doi.org/10.4172/2155-9864.1000376
https://doi.org/10.4172/2155-9864.1000376